The NGAL Test is a particle-enhanced turbidimetric immunoassay for the quantitative determination of neutrophil gelatinase-associated lipocalin (NGAL) in human urine, EDTA plasma, or heparin plasma on automated clinical chemistry analyzers. NGAL measurements are useful in the diagnosis of acute kidney injury, which may lead to acute renal failure.
The NGAL Test Reagent Kit
CAT NO: ST001
Cat. No. |
ST001 |
|---|---|
Kit Contents |
1 ready-to-use NGAL Buffer Solution (R1), 35 mL; 1 ready-to-use Immunoparticle suspension (R2), 7 mL; Instructions for Use |
Test Method |
Particle-enhanced turbidimetric immunoassay (PETIA) for use on automated clinical chemistry analyzers |
Sample Type |
Human urine, EDTA plasma, and heparin plasma |
Sample Stability |
1 day at room temperature (20-25ªC); 3 days at 2-8ºC; 1 year frozen at -70ºC or below, stable for 3 freeze/thaw cycles |
Number of Tests per Kit |
Approximately 100 determinants (Varies by analyzer.) |
Measuring Range |
50 ng/mL to 3000 ng/mL (Varies by analyzer.) |
Sample Analysis Time |
Approximately 10 minutes (Varies by analyzer.) |
Shelf Life |
24 months from manufacturing. See expiry date on the label. |
Storage |
Store at 2-8ºC |
Regulatory Status |
CE Marked and available for in vitro diagnostic use in the European Union; registered in Canada, Israel and Korea; available for Research Use Only in the United States. |
Patent Status |
This product is protected by one or more US, European and/or foreign patents. |